Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance01:07

Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance

304
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
304
Nonlinear Pharmacokinetics: Role of Transporters01:27

Nonlinear Pharmacokinetics: Role of Transporters

299
A drug's nonlinear kinetics can be influenced by a diverse range of transporter proteins that serve as crucial players in drug distribution. These transporters, found within cells, can enhance or reduce local drug concentrations by facilitating the influx or efflux of drugs. For instance, the expression of xenobiotic transporters can be influenced by factors such as age and gender, potentially impacting the linearity of drug response.
Polymorphisms occurring in drug transporters can alter...
299
Hepatic Drug Clearance: Role of Transporters01:14

Hepatic Drug Clearance: Role of Transporters

312
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
312
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance01:23

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

695
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
695
Psychology as a Science01:13

Psychology as a Science

4.0K
Psychology, as a scientific discipline, aims to understand the mind and behavior through rigorous and systematic methods. The foundation of psychological research is evidence-based, relying heavily on the scientific method to derive and validate knowledge. This structured approach ensures that findings are reliable, valid, and applicable to broader contexts.
The scientific method in psychology involves six critical steps: making observations, formulating hypotheses, conducting tests, analyzing...
4.0K
Overview of Biostatistics in Health Sciences01:19

Overview of Biostatistics in Health Sciences

5.3K
Biostatistics involves the application of statistical techniques to scientific research in health-related fields, including biology and public health. These techniques are essential for designing studies, collecting data, and analyzing it to draw meaningful conclusions. Given the complexity of biological processes, particularly in studies involving human subjects, biostatistical methods are crucial for effectively organizing and interpreting data that might otherwise obscure underlying patterns...
5.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluating the Utility and Constraints of the Competitive Counter Flow (CCF) Assay in OATP1B1 Substrate Profiling.

The AAPS journal·2026
Same author

Transcriptomic and metabolite-centric profiling reveal aryl hydrocarbon receptor-mediated cytochrome P450 1A1 autoinduction of the selective modulator PM-4321.

Drug metabolism and disposition: the biological fate of chemicals·2026
Same author

Comparative study of absorption prediction using human intestinal organoid-derived cells in static and flow conditions.

Drug metabolism and disposition: the biological fate of chemicals·2026
Same author

Biodistribution of Cerivastatin, Repaglinide, Glyburide, Rosuvastatin, and Valsartan in Cynomolgus Monkeys and PBPK Analysis.

The AAPS journal·2026
Same author

Comparative Analysis of Isavuconazole DDIs With Other Azole Antifungal Drugs and PBPK Model-Informed Dosing Recommendations for Anticancer Drugs.

CPT: pharmacometrics & systems pharmacology·2025
Same author

Significance of gut breast cancer resistance protein versus organic anion transporting polypeptide 2B1 inhibition on rosuvastatin clinical drug-drug interactions.

Drug metabolism and disposition: the biological fate of chemicals·2025
Same journal

Reduction of secondary 3-keto bile acids by aldo-keto reductase 1C1 and 1C4.

Drug metabolism and disposition: the biological fate of chemicals·2026
Same journal

High-level expression of full-length human CYP2E1 in Escherichia coli: Comparison of full-length human CYP2E1 to truncated counterpart shows enhanced association with redox partners.

Drug metabolism and disposition: the biological fate of chemicals·2026
Same journal

Construction of a curated human pharmacokinetics database for molecular fragment analysis and machine learning applications.

Drug metabolism and disposition: the biological fate of chemicals·2026
Same journal

Finding the dispersion number (D<sub>N</sub>) of the dispersion model from perfused rat and human liver studies.

Drug metabolism and disposition: the biological fate of chemicals·2026
Same journal

Role of organic anion transporting polypeptides in pancreatic statin disposition and islet cell function in mice.

Drug metabolism and disposition: the biological fate of chemicals·2026
Same journal

The regulatory potential of cytochrome P450-adrenodoxin interactions: Insights toward understanding redox partner regulation in drug metabolizing enzymes.

Drug metabolism and disposition: the biological fate of chemicals·2026
See all related articles

Related Experiment Video

Updated: Feb 13, 2026

Deriving the Time Course of Glutamate Clearance with a Deconvolution Analysis of Astrocytic Transporter Currents
09:42

Deriving the Time Course of Glutamate Clearance with a Deconvolution Analysis of Astrocytic Transporter Currents

Published on: August 7, 2013

10.9K

Navigating Transporter Sciences in Pharmacokinetics Characterization Using the Extended Clearance Classification

Ayman F El-Kattan1, Manthena V S Varma2

  • 1Pharmacokinetics Dynamics and Metabolism, Medicine Design, Pfizer Global Research and Development, Pfizer Inc., Cambridge, Massachusetts (A.F.E.-K.); and Pharmacokinetics Dynamics and Metabolism, Medicine Design, Pfizer Global Research and Development, Pfizer Inc., Groton, Connecticut (M.V.S.V.).

Drug Metabolism and Disposition: the Biological Fate of Chemicals
|March 3, 2018
PubMed
Summary
This summary is machine-generated.

Membrane transporters significantly impact drug absorption and elimination. The Extended Clearance Classification System (ECCS) helps predict drug clearance mechanisms and transporter roles early in development.

More Related Videos

Author Spotlight: Exploring Cellular Zinc Regulation Through ZnT1 Functionality
07:55

Author Spotlight: Exploring Cellular Zinc Regulation Through ZnT1 Functionality

Published on: June 2, 2023

1.7K
A Networked Desktop Virtual Reality Setup for Decision Science and Navigation Experiments with Multiple Participants
06:28

A Networked Desktop Virtual Reality Setup for Decision Science and Navigation Experiments with Multiple Participants

Published on: August 26, 2018

6.3K

Related Experiment Videos

Last Updated: Feb 13, 2026

Deriving the Time Course of Glutamate Clearance with a Deconvolution Analysis of Astrocytic Transporter Currents
09:42

Deriving the Time Course of Glutamate Clearance with a Deconvolution Analysis of Astrocytic Transporter Currents

Published on: August 7, 2013

10.9K
Author Spotlight: Exploring Cellular Zinc Regulation Through ZnT1 Functionality
07:55

Author Spotlight: Exploring Cellular Zinc Regulation Through ZnT1 Functionality

Published on: June 2, 2023

1.7K
A Networked Desktop Virtual Reality Setup for Decision Science and Navigation Experiments with Multiple Participants
06:28

A Networked Desktop Virtual Reality Setup for Decision Science and Navigation Experiments with Multiple Participants

Published on: August 26, 2018

6.3K

Area of Science:

  • Pharmacology
  • Drug Metabolism and Disposition
  • Biopharmaceutics

Background:

  • Membrane transporters are crucial for drug absorption, distribution, clearance, and elimination.
  • Key transporters include OATP, OAT, OCT, MATE, P-glycoprotein, and BCRP, with clinical relevance supported by pharmacokinetic data.
  • Understanding transporter roles early aids in predicting pharmacokinetics and evaluating drug-drug interactions (DDIs) and genetic polymorphisms.

Purpose of the Study:

  • To propose and discuss the application of an Extended Clearance Classification System (ECCS) for predicting drug clearance mechanisms.
  • To map the role of clinically relevant drug transporters in early drug discovery and development using the ECCS framework.
  • To optimize drug exposure and evaluate clinical risks associated with DDIs and pharmacogenomics.

Main Methods:

  • Development of the Extended Clearance Classification System (ECCS) based on drug properties: ionization, permeability, and molecular weight.
  • Classification of drugs into distinct groups based on predicted predominant clearance mechanisms (hepatic uptake, renal secretion, intestinal transport).
  • Application of the ECCS framework to map the involvement of specific transporters (e.g., OATP, OAT, OCT, MATE) in drug disposition.

Main Results:

  • The ECCS framework predicts that OATP-mediated hepatic uptake is key for class 1B and 3B drugs.
  • Renal clearance is predominant for class 3A, 4, and some 3B drugs, involving transporters like OAT1, OAT3, OCT2, and MATE proteins.
  • Intestinal transporters significantly influence oral pharmacokinetics for class 3A, 3B, and 4 drugs.

Conclusions:

  • The ECCS provides a valuable paradigm for early prediction of drug clearance and transporter involvement.
  • Applying ECCS facilitates strategic decision-making in drug development to optimize exposure and mitigate risks.
  • This approach aids in evaluating the clinical impact of DDIs and pharmacogenomic variations on drug therapy.